Glycosyltransferases and non-alcoholic fatty liver disease

被引:0
作者
Yu-Tao Zhan [1 ]
Hai-Ying Su [2 ]
Wei An [3 ]
机构
[1] Department of Gastroenterology, Beijing Tongren Hospital, Capital Medical University
[2] Department of Cell Biology, Municipal Laboratory for Liver Protection and Regulation of Regeneration, Capital Medical University
[3] Department of Obstetrics and Gynecology, Shandong Jining First People’s Hospital
基金
中国国家自然科学基金;
关键词
Non-alcoholic fatty liver disease; Pathogenesis; Glycosyltransferases; Glycosylation;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease(NAFLD) is the most common form of chronic liver disease and its incidence is increasing worldwide. However, the underlying mechanisms leading to the development of NAFLD are still not fully understood. Glycosyltransferases(GTs) are a diverse class of enzymes involved in catalyzing the transfer of one or multiple sugar residues to a wide range of acceptor molecules. GTs mediate a wide range of functions from structure and storage to signaling, and play a key role in many fundamental biological processes. Therefore, it is anticipated that GTs have a role in the pathogenesis of NAFLD. In this article, we present an overview of the basic information on NAFLD, particularly GTs and glycosylation modification of certain molecules and their association with NAFLD pathogenesis. In addition, the effects and mechanisms of some GTs in the development of NAFLD are summarized.
引用
收藏
页码:2483 / 2493
页数:11
相关论文
共 51 条
[1]   Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease:an update [J].
Vasilios G Athyros ;
Konstantinos Tziomalos ;
Niki Katsiki ;
Michael Doumas ;
Asterios Karagiannis ;
Dimitri P Mikhailidis .
World Journal of Gastroenterology, 2015, 21 (22) :6820-6834
[2]  
Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease[J]. Shao-Ren Zhang,Xiao-Ming Fan.World Journal of Gastroenterology. 2015(11)
[3]  
MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease[J]. Nadia Panera,Daniela Gnani,Annalisa Crudele,Sara Ceccarelli,Valerio Nobili,Anna Alisi.World Journal of Gastroenterology. 2014(41)
[4]   Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning? [J].
Bülent Baran ;
Filiz Akyüz .
World Journal of Gastroenterology, 2014, (39) :14219-14229
[5]   Nonalcoholic fatty liver disease and vascular disease:State-of-the-art [J].
Silvia Fargion ;
Marianna Porzio ;
Anna Ludovica Fracanzani .
World Journal of Gastroenterology, 2014, (37) :13306-13324
[6]   Non-alcoholic fatty liver disease: What the clinician needs to know [J].
Mariana Verdelho Machado ;
Helena Cortez-Pinto .
World Journal of Gastroenterology, 2014, 20 (36) :12956-12980
[7]   Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations [J].
Sandra Milic ;
Davorka Lulic ;
Davor Stimac .
World Journal of Gastroenterology, 2014, (28) :9330-9337
[9]   NAFLD prevalence differs among hispanic subgroups:The multi-ethnic study of atherosclerosis [J].
Michael Wayne Fleischman ;
Matthew Budoff ;
Ifran Zeb ;
Dong Li ;
Temitope Foster .
World Journal of Gastroenterology, 2014, 20 (17) :4987-4993
[10]  
Roles of liver innate immune cells in nonalcoholic fatty liver disease[J]. Yu-Tao Zhan, Department of Gastroenterology and Hepatology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China Wei An, Department of Cell Biology, Capital Medical University, Beijing 100069, China.World Journal of Gastroenterology. 2010(37)